Howard Hochster, MD, shares his perspective on the outcomes of the PRODIGY7 study in metastatic colorectal cancer patients using heated single agent oxaliplatin after surgery at the 2018 Annual Meeting.
metastatic colorectal cancer patients, prodigy7 study, mcrc, perspective on the outcomes
Advertisement